A Safety Study of SGN-LIV1A in Breast Cancer Patients

Clinical trial NCT01969643 · COMPLETED

Trial details

NCT number: NCT01969643
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2 Positive Breast Neoplasms Hormone Receptor Positive Breast Neoplasms Triple Negative Breast Neoplasms HER2 Mutations Breast Neoplasms

Start date: 2013-10-22
Primary completion: 2023-02-04
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.